Patent Assignment
Reel/Frame 066272/0079
Confirmatory License
Recorded: 2024-01-11
Pages: 2
Assignor
LYNDRA THERAPEUTICS, INC.
Executed: 2024-01-09
Assignee
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR), 6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980, BETHESDA, MARYLAND, 20892-7980
Covered Property
(1)
Gastric Residence Systems Comprising Buprenorphine and Naloxone
Application:
18/289,331 →
Publication:
US 2024/0252483
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 13, 2023
From: BHISE, NUPURA; KATSTRA, JEFFREY; ALTREUTER, DAVID
To: LYNDRA THERAPEUTICS, INC.
Reel/Frame 065541/0821 →
Assignment of Assignor's Interest
Nov 18, 2025
From: LYNDRA THERAPEUTICS, INC.
To: ISP ACQUISITION COMPANY, INC.
Reel/Frame 073610/0424 →
Change of Name
Nov 19, 2025
From: ISP ACQUISITION COMPANY, INC.
To: NORTIVA BIO, INC.
Reel/Frame 073607/0955 →